USFDA pulls up Sun Pharma for lapses in Gujarat plant
Image Credit: NewsBytes
The US Food and Drug Administration (USFDA) questioned India's top drugmaker Sun Pharma for alleged failures in preventing drug product contamination at its Gujarat-based factory, PTI reported. The health regulator issued a warning letter citing flaws at the Halol factory, which manufactures finished pharmaceutical goods. Notably, the warning was issued following an inspection conducted last year between April 26 and May 9.